BamSEC and AlphaSense Join Forces
Learn More

Centessa Pharmaceuticals plc – Material Contracts

Formerly NASDAQ: CNTA
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 18 pages Material contract
12/34/56
EX-10.14
from 10-K 43 pages Dated 28 April 2025 Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]” the Participants and Centessa Pharmaceuticals plc and Centessa Pharmaceuticals (Uk) Limited Deed of Amendment and Restatement Relating to the Incentivisation Deed Relating to Orexia Products
12/34/56
EX-10.1
from 8-K 12 pages Voting Agreement
12/34/56
EX-10.19
from 10-K 74 pages Execution Version Genmab Matter Number: 63646 1 License Agreement Between Genmab a/S as Genmab and Centessa Pharmaceuticals (Uk) Limited as Centessa
12/34/56
EX-10.18
from 10-K 66 pages Material contract
12/34/56
EX-10.17
from 10-K 26 pages Material contract
12/34/56
EX-10.15
from 10-K 42 pages Active/124996018.3 Dated 2024 Centessa Pharmaceuticals (Orexia) Limited and the Participants and Centessa Pharmaceuticals plc and Centessa Pharmaceuticals (Uk) Limited Deed of Novation and Amendment and Restatement Relating to the Incentivisation Deed Relating to Centessa Pharmaceuticals (Orexia) Limited 18 December
12/34/56
EX-10.13
from 10-K 42 pages Dated 2024 Lockbody Therapeutics Ltd and the Participants and Centessa Pharmaceuticals plc and Centessa Pharmaceuticals (Uk) Limited Deed of Novation and Amendment and Restatement Relating to the Incentivisation Deed Relating to Lockbody Therapeutics Ltd 18 March
12/34/56
EX-10.2
from 10-Q 9 pages Material contract
12/34/56
EX-10.1
from 10-Q 14 pages Material contract
12/34/56
EX-10.23
from 10-K 22 pages Certain Confidential Information Marked by [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential Strictly Private and Confidential Dated 1 October, 2021 Centessa Pharmaceuticals plc and David Grainger, Phd. Service Agreement
12/34/56
EX-10.22
from 10-K 12 pages Certain Confidential Information Marked by [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential Employment Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Amendment No. 3 to Note Purchase Agreement
12/34/56
EX-10.23
from 10-K 10 pages David Chao 5265 Sunset Drive Kansas City Mo 64112 USA April 08, 2021 3. Compensation and Related Matters
12/34/56
EX-10.21
from 10-K 10 pages Amendment No. 2 to Note Purchase Agreement
12/34/56
EX-10.35
from 10-K 71 pages Article 1 Basic Lease Provisions
12/34/56
EX-10.34
from 10-K 19 pages Amendment to Note Purchase Agreement and Waiver
12/34/56
EX-10.22
from 10-K 13 pages Employment Agreement
12/34/56
EX-10.5
from 10-K 13 pages Employment Agreement
12/34/56
EX-10
from 10-K 13 pages Employment Agreement
12/34/56